Primary, secondary, and tertiary prevention of pre-eclampsia
about
sameAs
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunctionAntithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunctionDiagnosis and management of preeclampsia in community settings in low and middle-income countriesPrediction of pre-eclampsia: a protocol for systematic reviews of test accuracyShear wave elastography of placenta: in vivo quantitation of placental elasticity in preeclampsiaMolecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).Aspirin plus calcium supplementation to prevent superimposed preeclampsia: a randomized trialRole of dyslipidemia in preeclamptic overweight pregnant womenGuidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Work-related maternal risk factors and the risk of pregnancy induced hypertension and preeclampsia during pregnancy. The Generation R StudyPlacental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model.The role of aspirin in women's healthManaging pregnancy in inflammatory rheumatological diseasesGenesis of preeclampsia: an epidemiological approachGenetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.Could antioxidant supplementation prevent pre-eclampsia?Functional Differences Between Placental Micro- and Macrovascular Endothelial Colony-Forming Cells.Beyond the threshold: an etiological bridge between hypoxia and immunity in preeclampsia.Risk factors on hypertensive disorders among Jordanian pregnant women.High maternal hemoglobin concentration in first trimester as risk factor for pregnancy induced hypertension.Predictive factors for preeclampsia in pregnant women: a Receiver Operation Character approachClinical study of fundus findings in pregnancy induced hypertension.Novel approaches for mechanistic understanding and predicting preeclampsia.Prediction and prevention of preeclampsia.Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: A prospective observational studyAngiogenic growth factors in the diagnosis and prediction of pre-eclampsia.Placental gene expression of the placental growth factor (PlGF) in intrauterine growth restriction.Potential role of folate in pre-eclampsia.Understanding Pre-Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint.Etiopathogenesis, prediction, and prevention of preeclampsia.Maternal physical morbidity associated with denial of pregnancy.Vasoconstriction caused by cocaine is enhanced by sodium salicylate: is inducible nitric oxide synthase mRNA related?The effect of glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia.A survey of Canadian practitioners regarding the management of the hypertensive disorders of pregnancy.Perinatal outcomes associated with maternal hypertensive disorders of pregnancy in a developing country.Biomarker Immunoassays in the Diagnosis of Preeclampsia: Calculating the sFlt1/PlGF Ratio Using the Cobas®e 411 Analyser.Early-onset preeclampsia and neonatal outcomes.Identification of two novel quantitative trait loci for pre-eclampsia susceptibility on chromosomes 5q and 13q using a variance components-based linkage approach.
P2860
Q24201073-2688DC2B-B1AF-416D-8461-E40930CA8FE1Q24235012-E38E7B00-FDF4-4FBA-9436-D15B208163E1Q26764860-6F0C03CF-2A78-44F1-B091-5B0599B472B8Q28200816-9CDA8A7D-AF86-4060-AC18-053DE999D4A9Q30408209-9B39E799-1A6F-4F07-8A0E-0976808EA7B3Q33349894-3B3DC0FD-2FD0-400D-9F3E-46A993F0F433Q33579089-7C7A2C33-C95E-4314-8096-432E924CE765Q33822209-F1039AE7-4CFB-45B5-A9D0-686188140E52Q34176478-2CAE1DB6-36AF-4BA6-8088-A025D9FEA7CBQ34299778-E4C73CEA-BC9C-433F-A0F2-8CA673C437C9Q34312335-71647B3F-2AFB-4D85-882B-A981D4165AA6Q34500006-2C70CC8B-2AB6-409A-8A89-78751A9581FBQ34987180-039FB313-0431-465C-8BF7-EC12600296FCQ35119642-B9DE6126-3639-402E-9BE1-2E20EEC808B8Q35169341-61760C9D-326E-4167-9464-BBCF4DE2774AQ35825336-49771BBC-F546-489D-9D0C-34314C110DEEQ36268948-BC10B871-F382-4B7E-8736-B601E08B9E73Q36325124-241CE591-C80F-4AB3-A8AF-1E2F7F2C7E71Q36728532-C4A5FB63-E71F-4D68-8812-18268AA4C0D7Q36752130-620F743B-7B47-4E45-9FF5-76E1837F4FE8Q36780030-BA2D4173-4682-448F-8159-9C54113BF731Q37155786-2C868435-0C44-4B98-A515-E13CCAACA3CBQ37180109-34391794-2CCD-44D1-808C-82E3AD02A396Q37374975-94D93EE4-7B87-4172-9DB2-889CEF1C4706Q37465594-F5EFB91C-7683-457F-92A8-19B1102B720DQ37479314-875C40F1-E970-437B-A7C6-F7B8BF4A1491Q37718889-33EB674C-63D7-4A87-AA4D-F956C4E6833FQ37935034-3906819C-117A-48EF-828E-E1E1B8A0671BQ38406326-1FFC0CF0-F976-4414-A88D-08A6CB26F337Q38584627-DDB73A91-455A-42B2-93E8-94E39CE06A37Q38638997-E5219D0C-6A35-46F1-8805-4294C81D07D8Q38868475-E684451C-7620-4230-AB2A-7F4D23BA05E2Q38987273-19413274-732C-4FFA-ADD5-FB623A7CCB0AQ44784150-87A985AB-8D24-474E-A7A1-7CCA896D807EQ44874948-999A4B66-E160-461B-BA5F-2066D96BF4EFQ44874950-CEF713F5-0839-4D4B-9FAF-B3CE400E0735Q44957496-701D960C-E733-494A-9E2A-9E2487585E60Q46301104-33D789E4-777A-42A7-9897-8CB337B6019BQ46305133-904F6256-59C0-4D4E-BA98-3D71263EA87BQ46340721-1CD4A488-38A0-4BE3-B1F4-328D696E46C6
P2860
Primary, secondary, and tertiary prevention of pre-eclampsia
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Primary, secondary, and tertiary prevention of pre-eclampsia
@ast
Primary, secondary, and tertiary prevention of pre-eclampsia
@en
Primary, secondary, and tertiary prevention of pre-eclampsia
@nl
type
label
Primary, secondary, and tertiary prevention of pre-eclampsia
@ast
Primary, secondary, and tertiary prevention of pre-eclampsia
@en
Primary, secondary, and tertiary prevention of pre-eclampsia
@nl
prefLabel
Primary, secondary, and tertiary prevention of pre-eclampsia
@ast
Primary, secondary, and tertiary prevention of pre-eclampsia
@en
Primary, secondary, and tertiary prevention of pre-eclampsia
@nl
P3181
P1433
P1476
Primary, secondary, and tertiary prevention of pre-eclampsia
@en
P2093
P304
P3181
P356
10.1016/S0140-6736(00)03599-6
P407
P577
2001-01-20T00:00:00Z